{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06214871",
            "orgStudyIdInfo": {
                "id": "2023-001"
            },
            "organization": {
                "fullName": "Gerrish MedEsthetics",
                "class": "INDUSTRY"
            },
            "briefTitle": "rTMS for Neuroenhancement",
            "officialTitle": "A Prospective Study To Evaluate Safety and Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) For Neuroenhancement",
            "therapeuticArea": [
                "Other"
            ],
            "study": "rtms-for-neuroenhancement"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-11-07",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-11",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-12-06",
            "studyFirstSubmitQcDate": "2024-01-16",
            "studyFirstPostDateStruct": {
                "date": "2024-01-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-23",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Gerrish MedEsthetics",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this pilot study is to evaluate the effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Sleep Quality, Mood and Memory."
        },
        "conditionsModule": {
            "conditions": [
                "Sleep"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Single Arm",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Device: rTMS"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "rTMS",
                    "description": "Transcranial Magnetic Stimulation",
                    "armGroupLabels": [
                        "Single Arm"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Sleep Quality - Jenkins Sleep Scale",
                    "description": "Jenkins Sleep Scale (Score can be from 0-20; higher scores equal lesser sleep quality)",
                    "timeFrame": "Various - Over 8 weeks"
                },
                {
                    "measure": "Sleep Quality - PHQ-9 (Patient Health Questionnaire-9)",
                    "description": "PHQ-9 (Question #3 score can be 0-3; higher score equal lesser sleep quality)",
                    "timeFrame": "Various - Over 8 Weeks"
                },
                {
                    "measure": "Sleep Quality - QIDS-SR (Quick Inventory of Depressive Symptomatology - Self Report)",
                    "description": "QIDS-SR (Questions #1-#4 each question can be 0-3; higher score equals lesser sleep quality)",
                    "timeFrame": "Various - Over 8 Weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Mood - PANAS (Positive and Negative Affect Schedule)",
                    "description": "Assessments; PANAS (20 Questions; The total score is calculated by finding the sum of the 10 positive items, and then the 10 negative items. Scores range from 10 - 50 for both sets of items. For the total positive score, a higher score indicates more of a positive affect. For the total negative score, a lower score indicates less of a negative affect)",
                    "timeFrame": "Various - Over 8 weeks"
                },
                {
                    "measure": "Memory - RAVLT Immediate Recall (Rey Auditory Verbal Learning Test)",
                    "description": "Assessment; RAVLT Immediate (the sum of scores from 5 first trials (Trials 1 to 5)),",
                    "timeFrame": "Various - Over 8 weeks"
                },
                {
                    "measure": "Mood - SAMMS (Sleep, Anxiety, Mood, Memory Survey)",
                    "description": "SAMMS (8 Questions; Total score ranges from 0-80; 2 of the questions are related to Mood and a higher score is better mood)",
                    "timeFrame": "Various - Over 8 Weeks"
                },
                {
                    "measure": "Mood - VAMS (Visual Analog Mood Scale)",
                    "description": "VAMS (7 Questions; Total score can range from 0-70; higher scores represent better Mood)",
                    "timeFrame": "Various - Over 8 Weeks"
                },
                {
                    "measure": "Memory - RAVLT Delayed Recall",
                    "description": "RAVLT Forgetting (the score of Trial 5 minus score of the delayed recall)",
                    "timeFrame": "Various - Over 8 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female, 22 to 70 years of age\n* Freely provides written informed consent\n* In good general health, as ascertained by medical history\n* If female, not breastfeeding, no known or suspected pregnancy, a status of non- childbearing potential or use of an acceptable form of birth control\n* If subject is in menopausal transition, the subject must be stabilized on hormonal treatment.\n* Subject scored a 2 or higher on PHQ-9 sleep related question (#3), OR subject scored 2 or more on at least 2 QIDS-SR sleep related questions (#'s 1-4)\n* If subject is on any psychiatric or sleep medication, dose must be stable for two weeks prior to enrollment and remain stable throughout the trial.\n\nExclusion Criteria:\n\n* Subject satisfies any one or more of the contraindications for TMS Therapy per current treatment guidelines as determined by the PI.\n* History of head trauma associated with loss of consciousness or diagnosed as concussion.\n* History of fainting, syncope, hearing problems or ringing in the ears (tinnitus)\n* Has any metallic implant(s) in or near the head (e.g., pacemaker, defibrillator, neurostimulator, etc.) including any splinters, fragments, clips, etc.\n* Has an implanted stimulator device (including device leads) in or near the head.\n\n  (e.g. deep brain stimulator, cochlear implant, vagus nerve stimulator.)\n* Has medication infusion device.\n* Subjects with any prior TMS or MRI complications which, in the opinion of the investigator, might interfere with safety, study participation, or which might confound data interpretation,\n* Current diagnosis of a Substance Use Disorder (Abuse or Dependence, as defined by DSM-IV-TR), with the exception of nicotine dependence.\n* Current diagnosis or known history of neurologic or neuropsychiatric disease (e.g., epilepsy, convulsion, seizure)\n* Has a clinically significant abnormality on the screening examination that might affect safety, study participation, or confound interpretation of study results.\n* Participation in any clinical trial with an investigational drug or device within the past month or concurrent with study participation.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "22 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Scott Gerrish",
                    "role": "CONTACT",
                    "phone": "703-255-5580",
                    "email": "drgerrish@hotmail.com"
                },
                {
                    "name": "Michele Duley",
                    "role": "CONTACT",
                    "phone": "703-255-5580",
                    "email": "michele@gerrishmedesthetics.com"
                }
            ],
            "locations": [
                {
                    "facility": "Gerrish MedEsthetics",
                    "status": "RECRUITING",
                    "city": "Vienna",
                    "state": "Virginia",
                    "zip": "22180",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Scott Gerrish",
                            "role": "CONTACT",
                            "phone": "703-255-5580",
                            "email": "drgerrish@hotmail.com"
                        },
                        {
                            "name": "Michele Duley",
                            "role": "CONTACT",
                            "phone": "703-255-5580",
                            "email": "michele@gerrishmedesthetics.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.90122,
                        "lon": -77.26526
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        }
    },
    "hasResults": false
}